NCT05853367View on ClinicalTrials.gov

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

PHASE1RecruitingINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

February 12, 2028

Study Completion Date

February 12, 2028

Conditions
Metastatic Solid TumorsAdvanced Solid Tumors
Interventions
DRUG

MK-0472

Oral Administration

BIOLOGICAL

Pembrolizumab

IV infusion

DRUG

MK-1084

Oral Administration

Trial Locations (25)

1211

RECRUITING

Hôpitaux Universitaires de Genève (HUG) ( Site 0202), Geneva

6500

RECRUITING

Ospedale Regionale Bellinzona e Valli ( Site 0200), Bellinzona

9000

RECRUITING

Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 0201), Sankt Gallen

28050

RECRUITING

Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid, ( Site 0504), Madrid

40202

RECRUITING

The University of Louisville, James Graham Brown Cancer Center ( Site 0004), Louisville

41013

RECRUITING

Hospital Virgen del Rocio ( Site 0503), Seville

60611

RECRUITING

Northwestern Memorial Hospital ( Site 0002), Chicago

3109601

RECRUITING

Rambam Health Care Campus ( Site 0304), Haifa

4941492

RECRUITING

Rabin Medical Center ( Site 0301), Petah Tikva

5265601

RECRUITING

Sheba Medical Center ( Site 0300), Ramat Gan

6423906

RECRUITING

Sourasky Medical Center ( Site 0302), Tel Aviv

7500653

RECRUITING

Centro de Estudios Clínicos SAGA ( Site 0701), Santiago

7500921

RECRUITING

Fundacion Arturo Lopez Perez ( Site 0700), Santiago

8330034

RECRUITING

Centro de Investigacion Clinicadela Universidad Catolica ( Site 0703), Santiago

8420383

RECRUITING

Bradfordhill ( Site 0702), Santiago

9103102

RECRUITING

Shaare Zedek Medical Center ( Site 0303), Jerusalem

07601

RECRUITING

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack

08901

RECRUITING

Rutgers Cancer Institute of New Jersey ( Site 0005), New Brunswick

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre ( Site 0101), Toronto

H2X 0A9

RECRUITING

Centre Hospitalier de l'Université de Montréal-Unit for Innovative Therapies ( Site 0100), Montreal

H3T 1E2

RECRUITING

Jewish General Hospital ( Site 0104), Montreal

02-781

RECRUITING

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 0401), Warsaw

80-214

RECRUITING

Uniwersyteckie Centrum Kliniczne ( Site 0400), Gdansk

08907

RECRUITING

Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 0501), L'Hospitalet de Llobregat

08035

RECRUITING

Hospital Universitari Vall d'Hebron ( Site 0500), Barcelona

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY